5 Simple Techniques For semaglutude Weeks 13-16 Bundle
The demo reached both its Major endpoints, with semaglutide 2.4 mg demonstrating statistically considerable and excellent advancements in liver fibrosis without any worsening of steatohepatitis, along with resolution of steatohepatitis without any worsening of liver fibrosis in individuals with MASH when compared to placebo.oneConvey to your health